Cochlear Future Growth
Future criteria checks 3/6
Cochlear is forecast to grow earnings and revenue by 13.4% and 9.2% per annum respectively while EPS is expected to grow by 1.7% per annum.
Key information
13.4%
Earnings growth rate
1.7%
EPS growth rate
Medical Equipment earnings growth | 0% |
Revenue growth rate | 9.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 02 Jun 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 2,247 | 399 | 347 | 463 | 18 |
6/30/2024 | 2,068 | 351 | 307 | 416 | 19 |
6/30/2023 | 1,856 | 300 | 230 | 337 | 19 |
12/31/2022 | 1,713 | 261 | 259 | 341 | N/A |
9/30/2022 | 1,681 | 275 | 279 | 359 | N/A |
6/30/2022 | 1,648 | 289 | 299 | 377 | N/A |
3/31/2022 | 1,612 | 273 | 266 | 340 | N/A |
12/31/2021 | 1,575 | 257 | 233 | 304 | N/A |
9/30/2021 | 1,536 | 291 | 216 | 285 | N/A |
6/30/2021 | 1,498 | 324 | 199 | 265 | N/A |
3/31/2021 | 1,403 | 82 | -52 | 34 | N/A |
12/31/2020 | 1,308 | -160 | -302 | -198 | N/A |
9/30/2020 | 1,314 | -199 | -295 | -178 | N/A |
6/30/2020 | 1,321 | -238 | -288 | -158 | N/A |
3/31/2020 | 1,400 | 34 | -80 | 50 | N/A |
12/31/2019 | 1,479 | 306 | 128 | 259 | N/A |
9/30/2019 | 1,453 | 291 | 155 | 277 | N/A |
6/30/2019 | 1,427 | 277 | 181 | 296 | N/A |
3/31/2019 | 1,422 | 270 | 217 | 313 | N/A |
12/31/2018 | 1,418 | 264 | 252 | 330 | N/A |
9/30/2018 | 1,391 | 255 | 230 | 294 | N/A |
6/30/2018 | 1,364 | 246 | 208 | 258 | N/A |
3/31/2018 | 1,329 | 234 | 194 | 254 | N/A |
12/31/2017 | 1,294 | 223 | 180 | 250 | N/A |
9/30/2017 | 1,274 | 223 | 184 | 255 | N/A |
6/30/2017 | 1,254 | 224 | 189 | 260 | N/A |
3/31/2017 | 1,218 | 215 | 182 | 237 | N/A |
12/31/2016 | 1,182 | 206 | 176 | 214 | N/A |
9/30/2016 | 1,156 | 198 | N/A | 199 | N/A |
6/30/2016 | 1,131 | 189 | N/A | 185 | N/A |
3/31/2016 | 1,088 | 179 | N/A | 179 | N/A |
12/31/2015 | 1,045 | 168 | N/A | 172 | N/A |
9/30/2015 | 986 | 157 | N/A | 181 | N/A |
6/30/2015 | 926 | 146 | N/A | 189 | N/A |
3/31/2015 | 899 | 145 | N/A | 178 | N/A |
12/31/2014 | 872 | 144 | N/A | 168 | N/A |
9/30/2014 | 839 | 119 | N/A | 140 | N/A |
6/30/2014 | 805 | 94 | N/A | 111 | N/A |
3/31/2014 | 769 | 85 | N/A | 93 | N/A |
12/31/2013 | 732 | 76 | N/A | 75 | N/A |
9/30/2013 | 742 | 104 | N/A | 72 | N/A |
6/30/2013 | 753 | 133 | N/A | 70 | N/A |
3/31/2013 | 768 | 144 | N/A | 100 | N/A |
12/31/2012 | 783 | 155 | N/A | 129 | N/A |
9/30/2012 | 781 | 106 | N/A | 149 | N/A |
6/30/2012 | 779 | 57 | N/A | 168 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COH N's forecast earnings growth (13.4% per year) is above the savings rate (7.6%).
Earnings vs Market: COH N's earnings (13.4% per year) are forecast to grow faster than the MX market (9.2% per year).
High Growth Earnings: COH N's earnings are forecast to grow, but not significantly.
Revenue vs Market: COH N's revenue (9.2% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: COH N's revenue (9.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COH N's Return on Equity is forecast to be high in 3 years time